Schroder Investment Management Group Sells 74,257 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Schroder Investment Management Group lessened its position in shares of Dolby Laboratories, Inc. (NYSE:DLBFree Report) by 6.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,103,697 shares of the electronics maker’s stock after selling 74,257 shares during the quarter. Schroder Investment Management Group owned 1.16% of Dolby Laboratories worth $86,155,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Fifth Third Bancorp lifted its stake in shares of Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 163 shares during the period. Nisa Investment Advisors LLC increased its holdings in Dolby Laboratories by 436.2% during the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker’s stock valued at $29,000 after buying an additional 301 shares during the last quarter. Mather Group LLC. raised its position in Dolby Laboratories by 36.8% in the fourth quarter. Mather Group LLC. now owns 528 shares of the electronics maker’s stock worth $41,000 after acquiring an additional 142 shares during the period. GAMMA Investing LLC boosted its stake in shares of Dolby Laboratories by 207.5% during the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker’s stock worth $61,000 after acquiring an additional 525 shares during the last quarter. Finally, Wealthfront Advisers LLC bought a new stake in shares of Dolby Laboratories during the 4th quarter valued at $94,000. Institutional investors own 58.56% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on DLB shares. Rosenblatt Securities reaffirmed a “buy” rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Thursday, January 30th. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price objective on shares of Dolby Laboratories in a research report on Thursday, February 13th. Finally, StockNews.com downgraded Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research note on Friday, January 31st.

Get Our Latest Analysis on DLB

Dolby Laboratories Stock Performance

DLB opened at $79.94 on Monday. The stock has a market cap of $7.63 billion, a price-to-earnings ratio of 29.39 and a beta of 1.01. The firm’s fifty day moving average is $82.25 and its 200 day moving average is $78.32. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.66.

Dolby Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 19th. Stockholders of record on Tuesday, February 11th were given a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, February 11th. This represents a $1.32 annualized dividend and a dividend yield of 1.65%. Dolby Laboratories’s payout ratio is 48.53%.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, CMO Todd Pendleton sold 18,121 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total value of $1,517,633.75. Following the sale, the chief marketing officer now owns 37,290 shares in the company, valued at $3,123,037.50. The trade was a 32.70 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Mark Andrew Sherman sold 40,000 shares of the firm’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $84.88, for a total value of $3,395,200.00. Following the transaction, the executive vice president now owns 62,397 shares of the company’s stock, valued at approximately $5,296,257.36. The trade was a 39.06 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 65,121 shares of company stock valued at $5,501,324 over the last 90 days. Company insiders own 38.39% of the company’s stock.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.